CURIS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period
CURIS, INC. (CRIS) reported Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period of 1.04 million shares for the 12-month period ending 2014-12-31, per its 10-K filed 2018-03-08.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod · last filed 2018-03-08
- CURIS, INC. share-based compensation arrangement by share-based payment award, shares issued in period for the quarter ending 2014-12-31 was 0.00 shares.
- CURIS, INC. share-based compensation arrangement by share-based payment award, shares issued in period for fiscal 2014 was 1.04M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period 12 month |
|---|---|---|---|
| 2014-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | 1.04M shares 10-K · filed 2018-03-08 | |
| 2014-09-30 | 1.04M shares 10-Q · filed 2014-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |